Skip to content

Clinical trials

Phase 2 Thrombocytopenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 2 Country / region: United States Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20055
20061
20071
20082
20096
20108
20113
20122
20133
20143
20151
20171
20181
20191
20204
20212
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated17
Recruiting3
Withdrawn3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)9
M.D. Anderson Cancer Center5
GlaxoSmithKline4
Memorial Sloan Kettering Cancer Center4
Eisai Inc.2
National Institutes of Health Clinical Center (CC)2
Novartis Pharmaceuticals2
Shionogi2
Weill Medical College of Cornell University2
Alliance for Clinical Trials in Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia55
Anemia9
Neutropenia9
Anemia, Aplastic8
Autoimmune Diseases8
Leukemia6
Primary Myelofibrosis6
Purpura, Thrombocytopenic, Idiopathic6
Leukemia, Lymphocytic, Chronic, B-Cell5
Hematologic Diseases4

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.